Atyr Pharma Inc. (ATYR)
NASDAQ · Healthcare
Atyr Pharma Inc. EBITDA 2019–2025
Atyr Pharma Inc. annual/quarterly ebitda history and growth rate from 2019 to 2025. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Atyr Pharma Inc. ebitda for the quarter ending March 31, 2025 was -15.6 M, a 5.18% decrease year-over-year.
- Atyr Pharma Inc. ebitda for the twelve months ending March 31, 2025 was -42.8 M.
- Atyr Pharma Inc. annual ebitda for 2025 was -77.0 M, a 14.52% increase from 2024.
- Atyr Pharma Inc. annual ebitda for 2024 was -67.2 M, a 23.71% increase from 2023.
- Atyr Pharma Inc. annual ebitda for 2023 was -54.3 M, a 17.66% increase from 2022.
- Atyr Pharma Inc. annual ebitda for 2022 was -46.2 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
Atyr Pharma Inc. EBITDA — FAQ
Atyr Pharma Inc. (ATYR) ebitda over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ATYR's ebitda history?
The chart and table above show Atyr Pharma Inc.'s ebitda by year and by quarter, including the growth rate.